Transition State Analogue Inhibitors of 5′-Deoxyadenosine/5′-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis

Hilda A. Namanja-Magliano, Gary B. Evans, Rajesh K. Harijan, Peter C. Tyler, Vern L. Schramm

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mycobacterium tuberculosis 5′-deoxyadenosine/5′-methylthioadenosine nucleosidase (Rv0091) catalyzes the N-riboside hydrolysis of its substrates 5′-methylthioadenosine (MTA) and 5′-deoxyadenosine (5′-dAdo). 5′-dAdo is the preferred substrate, a product of radical S-adenosylmethionine-dependent enzyme reactions. Rv0091 is characterized by a ribocation-like transition state, with low N-ribosidic bond order, an N7-protonated adenine leaving group, and an activated but weakly bonded water nucleophile. DADMe-Immucillins incorporating 5′-substituents of the substrates 5′-dAdo and MTA were synthesized and characterized as inhibitors of Rv0091. 5′-Deoxy-DADMe-Immucillin-A was the most potent among the 5′-dAdo transition state analogues with a dissociation constant of 640 pM. Among the 5′-thio substituents, hexylthio-DADMe-Immucillin-A was the best inhibitor at 87 pM. The specificity of Rv0091 for the Immucillin transition state analogues differs from those of other bacterial homologues because of an altered hydrophobic tunnel accepting the 5′-substituents. Inhibitors of Rv0091 had weak cell growth effects on M. tuberculosis or Mycobacterium smegmatis but were lethal toward Helicobacter pylori, where the 5′-methylthioadenosine nucleosidase is essential in menaquinone biosynthesis. We propose that Rv0091 plays a role in 5′-deoxyadenosine recycling but is not essential for growth in these Mycobacteria.

Original languageEnglish (US)
Pages (from-to)5090-5098
Number of pages9
JournalBiochemistry
Volume56
Issue number38
DOIs
StatePublished - Sep 26 2017

Fingerprint

Mycobacterium tuberculosis
Substrates
Mycobacterium smegmatis
Vitamin K 2
S-Adenosylmethionine
Nucleophiles
Biosynthesis
Recycling
Cell growth
Adenine
Mycobacterium
Growth
Helicobacter pylori
5'-methylthioadenosine phosphorylase
5'-deoxyadenosine
5'-methylthioadenosine
Hydrolysis
Tunnels
Water
Enzymes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Transition State Analogue Inhibitors of 5′-Deoxyadenosine/5′-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis. / Namanja-Magliano, Hilda A.; Evans, Gary B.; Harijan, Rajesh K.; Tyler, Peter C.; Schramm, Vern L.

In: Biochemistry, Vol. 56, No. 38, 26.09.2017, p. 5090-5098.

Research output: Contribution to journalArticle

Namanja-Magliano, Hilda A. ; Evans, Gary B. ; Harijan, Rajesh K. ; Tyler, Peter C. ; Schramm, Vern L. / Transition State Analogue Inhibitors of 5′-Deoxyadenosine/5′-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis. In: Biochemistry. 2017 ; Vol. 56, No. 38. pp. 5090-5098.
@article{410258cd15f641229e4950e0384b23b1,
title = "Transition State Analogue Inhibitors of 5′-Deoxyadenosine/5′-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis",
abstract = "Mycobacterium tuberculosis 5′-deoxyadenosine/5′-methylthioadenosine nucleosidase (Rv0091) catalyzes the N-riboside hydrolysis of its substrates 5′-methylthioadenosine (MTA) and 5′-deoxyadenosine (5′-dAdo). 5′-dAdo is the preferred substrate, a product of radical S-adenosylmethionine-dependent enzyme reactions. Rv0091 is characterized by a ribocation-like transition state, with low N-ribosidic bond order, an N7-protonated adenine leaving group, and an activated but weakly bonded water nucleophile. DADMe-Immucillins incorporating 5′-substituents of the substrates 5′-dAdo and MTA were synthesized and characterized as inhibitors of Rv0091. 5′-Deoxy-DADMe-Immucillin-A was the most potent among the 5′-dAdo transition state analogues with a dissociation constant of 640 pM. Among the 5′-thio substituents, hexylthio-DADMe-Immucillin-A was the best inhibitor at 87 pM. The specificity of Rv0091 for the Immucillin transition state analogues differs from those of other bacterial homologues because of an altered hydrophobic tunnel accepting the 5′-substituents. Inhibitors of Rv0091 had weak cell growth effects on M. tuberculosis or Mycobacterium smegmatis but were lethal toward Helicobacter pylori, where the 5′-methylthioadenosine nucleosidase is essential in menaquinone biosynthesis. We propose that Rv0091 plays a role in 5′-deoxyadenosine recycling but is not essential for growth in these Mycobacteria.",
author = "Namanja-Magliano, {Hilda A.} and Evans, {Gary B.} and Harijan, {Rajesh K.} and Tyler, {Peter C.} and Schramm, {Vern L.}",
year = "2017",
month = "9",
day = "26",
doi = "10.1021/acs.biochem.7b00576",
language = "English (US)",
volume = "56",
pages = "5090--5098",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "38",

}

TY - JOUR

T1 - Transition State Analogue Inhibitors of 5′-Deoxyadenosine/5′-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis

AU - Namanja-Magliano, Hilda A.

AU - Evans, Gary B.

AU - Harijan, Rajesh K.

AU - Tyler, Peter C.

AU - Schramm, Vern L.

PY - 2017/9/26

Y1 - 2017/9/26

N2 - Mycobacterium tuberculosis 5′-deoxyadenosine/5′-methylthioadenosine nucleosidase (Rv0091) catalyzes the N-riboside hydrolysis of its substrates 5′-methylthioadenosine (MTA) and 5′-deoxyadenosine (5′-dAdo). 5′-dAdo is the preferred substrate, a product of radical S-adenosylmethionine-dependent enzyme reactions. Rv0091 is characterized by a ribocation-like transition state, with low N-ribosidic bond order, an N7-protonated adenine leaving group, and an activated but weakly bonded water nucleophile. DADMe-Immucillins incorporating 5′-substituents of the substrates 5′-dAdo and MTA were synthesized and characterized as inhibitors of Rv0091. 5′-Deoxy-DADMe-Immucillin-A was the most potent among the 5′-dAdo transition state analogues with a dissociation constant of 640 pM. Among the 5′-thio substituents, hexylthio-DADMe-Immucillin-A was the best inhibitor at 87 pM. The specificity of Rv0091 for the Immucillin transition state analogues differs from those of other bacterial homologues because of an altered hydrophobic tunnel accepting the 5′-substituents. Inhibitors of Rv0091 had weak cell growth effects on M. tuberculosis or Mycobacterium smegmatis but were lethal toward Helicobacter pylori, where the 5′-methylthioadenosine nucleosidase is essential in menaquinone biosynthesis. We propose that Rv0091 plays a role in 5′-deoxyadenosine recycling but is not essential for growth in these Mycobacteria.

AB - Mycobacterium tuberculosis 5′-deoxyadenosine/5′-methylthioadenosine nucleosidase (Rv0091) catalyzes the N-riboside hydrolysis of its substrates 5′-methylthioadenosine (MTA) and 5′-deoxyadenosine (5′-dAdo). 5′-dAdo is the preferred substrate, a product of radical S-adenosylmethionine-dependent enzyme reactions. Rv0091 is characterized by a ribocation-like transition state, with low N-ribosidic bond order, an N7-protonated adenine leaving group, and an activated but weakly bonded water nucleophile. DADMe-Immucillins incorporating 5′-substituents of the substrates 5′-dAdo and MTA were synthesized and characterized as inhibitors of Rv0091. 5′-Deoxy-DADMe-Immucillin-A was the most potent among the 5′-dAdo transition state analogues with a dissociation constant of 640 pM. Among the 5′-thio substituents, hexylthio-DADMe-Immucillin-A was the best inhibitor at 87 pM. The specificity of Rv0091 for the Immucillin transition state analogues differs from those of other bacterial homologues because of an altered hydrophobic tunnel accepting the 5′-substituents. Inhibitors of Rv0091 had weak cell growth effects on M. tuberculosis or Mycobacterium smegmatis but were lethal toward Helicobacter pylori, where the 5′-methylthioadenosine nucleosidase is essential in menaquinone biosynthesis. We propose that Rv0091 plays a role in 5′-deoxyadenosine recycling but is not essential for growth in these Mycobacteria.

UR - http://www.scopus.com/inward/record.url?scp=85029921928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029921928&partnerID=8YFLogxK

U2 - 10.1021/acs.biochem.7b00576

DO - 10.1021/acs.biochem.7b00576

M3 - Article

C2 - 28836767

AN - SCOPUS:85029921928

VL - 56

SP - 5090

EP - 5098

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 38

ER -